Related Experiment Video
Updated: Jan 18, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Aortic stenosis and peripheral artery disease: Impact on mortality following transcatheter aortic valve replacement
Martin Faure1, Louis Le Bivic2, Marouane Boukhris2
1Department of Clinical and Research Data Center, Limoges University Hospital, 87000 Limoges, France; Inserm U1094, IRD UMR270, EpiMaCT - Epidemiology of chronic diseases in tropical zone, OmegaHealth, University of Limoges, Limoges University Hospital, 87025 Limoges, France.
Background:
Due to common pathophysiology and shared risk factors, peripheral artery disease (PAD) is frequently present in patients with calcific aortic stenosis (AS). However, the prevalence of PAD in calcific AS and its prognostic impact require further investigation.
Aims:
To describe the prevalence of PAD in patients with advanced AS requiring intervention and assess the impact of PAD on overall long-term mortality among patients undergoing transcatheter aortic valve replacement (TAVR).
Methods:
All patients who underwent TAVR between 2014 and 2023 in our tertiary care centre were enrolled in a retrospective cohort. PAD was defined by the mention of a clinical diagnosis in medical records, significant arterial stenosis observed on the pre-procedural angio-computed tomography scan or a history of lower-limb revascularization.
Results:
Among the 904 included patients (median [interquartile range] age 84.2 (79.9-87.4) years, 54.4% male), 212 (23.5%) had PAD. Patients with PAD had a significantly higher risk of mortality compared to patients without PAD (mean 5-year survival 40.0%, 95% confidence interval [CI] 32.2-49.6 vs. 52.7%, 95% CI 47.8-58.1; P=0.008; adjusted hazard ratio [aHR] 1.31, 95% confidence interval [CI] 1.03-1.66; P=0.029). Among patients without coronary artery disease (CAD), those with PAD alone had an increased risk of mortality (aHR 1.50, 95% CI 1.03-2.21; P=0.037). Importantly, patients with PAD alone had significantly reduced survival compared to those with CAD alone (i.e. without PAD) (aHR 1.49, 95% CI 1.02-2.19; P=0.040). However, the survival of patients with both PAD and CAD did not significantly differ from those with CAD without PAD.
Conclusion:
PAD was independently associated with increased mortality in severe calcific AS. Importantly, this excess mortality among patients with PAD was not affected by the simultaneous presence of CAD. Similarly to patients with CAD, patients with AS and concomitant PAD should be considered at high risk of mortality.
More Related Videos
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Aneurysm IV: Nursing Management

